HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Stephen C. Yang Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yang, S. C. Search for Related Content PubMed PubMed Citation Articles by Yang, S. C. Related Collections Lung - cancer Related Article

---

Original Articles: General Thoracic

Invited Commentary

Division of Thoracic Surgery, The Johns Hopkins Medical Institutions, 600 N. Wolfe St, Blalock 240, Baltimore, MD 21287

(Email: syang@jhmi.edu).

The first 20% of the full text of this article appears below.

The optimal management of patients with N2 disease remains one of the most contentious areas of care for patients with nonsmall cell lung cancer (NSCLC). This is likely due to the wide pathologic variations in this stage. Defranchi and colleagues [1] present a series of 59 patients from a cohort of 968 who had clinical stage I disease and were found to have incidental N2 disease after surgical resection. Although a little more than half of the patients had . . . [Full Text of this Article]

Related Article

N2 Disease in T1 Non-Small Cell Lung Cancer

Sebastian A. Defranchi, Stephen D. Cassivi, Francis C. Nichols, Mark S. Allen, K. Robert Shen, Claude Deschamps, and Dennis A. Wigle
Ann. Thorac. Surg. 2009 88: 924-928. [Abstract] [Full Text] [PDF]